NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-120-2016-1-EP-03 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE EP National Stage 17742333.2 Issued
NHLBI E-120-2016-1-SE-19 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE SE EP 17742333.2 Issued
NHLBI E-120-2016-1-NO-18 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE NO EP 17742333.2 Issued
NHLBI E-120-2016-1-DK-13 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE DK EP 17742333.2 Issued
NHLBI E-120-2016-1-GB-15 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE GB EP 17742333.2 Issued
NHLBI E-120-2016-1-CH-11 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE CH EP 17742333.2 Issued
NHLBI E-120-2016-1-FR-14 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE FR EP 17742333.2 Issued
NHLBI E-120-2016-1-DE-12 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE DE EP 17742333.2 Issued
NHLBI E-120-2016-1-JP-05 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE JP National Stage 2018-567933 Issued
NCI E-267-2016-0-US-05 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases US National Stage 15/639,434 10363286 Issued PDF
NHLBI E-120-2016-1-PCT-01 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE PCT PCT COMB PCT/US17/040448 Expired
NCI E-183-2017-0-US-01 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains US 62/527,556 Abandoned
NCI E-094-2017-1-US-01 FULLY HUMAN ANTIBODIES THAT BIND HUMAN MESOTHELIN AND METHODS OF THEIR USE US 62/527,163 Abandoned
NCI E-116-2017-1-US-01 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR CD33 AND METHODS OF THEIR USE US 62/527,165 Abandoned
NCATS E-190-2016-0-CN-05 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof CN National Stage 2017800524475 Issued
NCATS E-190-2016-0-HK-09 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof HK EP 19131870.8 Issued
NIAID E-060-2015-0-US-07 Novel Multivalent Nanoparticle-Based Vaccines US National Stage 15/540,898 11191727 Issued PDF
NCATS E-190-2016-0-IE-13 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof IE EP 17737708.2 Issued
NCATS E-190-2016-0-EP-06 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof EP National Stage 17737708.2 Issued
NCATS E-190-2016-0-DE-10 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof DE EP 17737708.2 Issued
NCATS E-190-2016-0-FR-11 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof FR EP 17737708.2 Issued
NCATS E-190-2016-0-GB-12 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof GB EP 17737708.2 Issued
NCATS E-244-2014-0-US-08 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof US National Stage 15/540,893 10351532 Issued PDF
NIAID E-174-2016-0-PCT-02 USE OF AN INHIBITOR OF HEME DEGRADATION TO IMPROVE ANTIBIOTIC TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTION PCT PCT PCT/US17/039935 Expired
NCATS E-190-2016-0-PCT-02 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof PCT PCT PCT/US2017/040021 Expired
NCATS E-190-2016-0-JP-07 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof JP National Stage 2018-567635 Pending
NCATS E-190-2016-0-CA-04 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof CA National Stage 3029489 Pending
NCATS E-190-2016-0-AU-03 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof AU National Stage 2017290233 Abandoned
NIAID E-060-2015-0-JP-11 Novel Multivalent Nanoparticle-Based Vaccines JP National Stage 2017-534796 Issued
NHGRI E-243-2012-0-US-05 Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US CON 15/633,964 10307469 Issued PDF
NIAID E-270-2015-0-PCT-02 SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES FOR DISPLAY OF CO-ASSEMBLED TRIMERIC ANTIGENS PCT PCT PCT/US17/039595 Expired
NIAID E-270-2015-0-EP-03 SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES FOR DISPLAY OF CO-ASSEMBLED TRIMERIC ANTIGENS EP National Stage 17758969.4 Abandoned
NIAID E-081-2013-5-US-02 PREFUSION RSV F PROTEINS AND THEIR USE US DIV 15/633,578 10858400 Issued PDF
NCI E-179-2017-0-US-01 Macrocyclic Peptidomimetic Of The Polo-box Domain Of Polo-like Kinase 1 And Methods Of Use US 62/525,160 Abandoned
NIAID E-260-2014-0-US-04 RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US National Stage 15/539,640 10420834 Issued PDF
NCATS E-043-2017-3-PCT-01 Pharmaceutical Compositions With Antiflaviviral Activity PCT PCT COMB PCT/US2017/039071 Expired
NIAID E-060-2015-0-SG-13 Novel Multivalent Nanoparticle-Based Vaccines SG National Stage 11201705264W Abandoned
NCATS E-243-2014-0-JP-07 Mutant IDH1 Inhibitors Useful for Treating Cancer JP National Stage 2017534314 Issued
NICHD E-039-2015-0-JP-07 Adeno-Associated Virus Vectors Encoding Modified G6PC and Uses Thereof JP National Stage 2017-533845 Issued
NCI E-108-2004-1-US-10 METHODS FOR INDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS US CON 15/630,751 10697975 Expired PDF
NICHD E-039-2015-0-US-08 ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF US National Stage 15/538,852 10415044 Issued PDF
NHLBI E-254-2003-3-US-22 USE OF NITRITE SALTS FOR THE TREATMENT OF CARDIOVASCULAR CONDITIONS US DIV 15/630,017 Abandoned
NCATS E-104-2017-0-US-01 Dual Inhibitors of Phosphoinositide 3-Kinase and Histone Deacetylase For Treatment Of Cancer US 62/523,390 Abandoned
NCATS E-189-2016-0-CN-06 Mutant IDH1 Inhibitors Useful for Treating Cancer CN National Stage 2017800514100 Issued
NCATS E-189-2016-0-JP-08 Mutant IDH1 Inhibitors Useful for Treating Cancer JP National Stage 2018-567108 Issued
NCATS E-189-2016-0-AU-04 Mutant IDH1 Inhibitors Useful for Treating Cancer AU National Stage 2017281088 Issued
NCATS E-189-2016-0-EP-07 Mutant IDH1 Inhibitors Useful for Treating Cancer EP National Stage 17735296.0 Issued
NCATS E-189-2016-0-GB-12 Mutant IDH1 Inhibitors Useful for Treating Cancer GB EP 17735296.0 Issued
NCATS E-189-2016-0-IT-13 Mutant IDH1 Inhibitors Useful for Treating Cancer IT EP 17735296.0 Issued
NCATS E-189-2016-0-ES-10 Mutant IDH1 Inhibitors Useful for Treating Cancer ES EP 17735296.0 Issued